vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $15.8M, roughly 2.0× Spire Global, Inc.). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -176.6%, a 144.5% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -26.9%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-16.2M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -32.6%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.
LFCR vs SPIR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $15.8M |
| Net Profit | $-10.0M | $-28.0M |
| Gross Margin | 25.0% | 40.2% |
| Operating Margin | -9.9% | -164.1% |
| Net Margin | -32.1% | -176.6% |
| Revenue YoY | -4.5% | -26.9% |
| Net Profit YoY | -52.0% | 42.7% |
| EPS (diluted) | $-0.29 | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $15.8M | ||
| Q3 25 | $31.1M | $12.7M | ||
| Q2 25 | — | $19.2M | ||
| Q1 25 | $35.2M | $23.9M | ||
| Q4 24 | $32.6M | $21.7M | ||
| Q3 24 | $24.7M | $28.6M | ||
| Q2 24 | — | $25.4M | ||
| Q1 24 | $35.7M | $34.8M |
| Q4 25 | — | $-28.0M | ||
| Q3 25 | $-10.0M | $-19.7M | ||
| Q2 25 | — | $119.6M | ||
| Q1 25 | $-14.8M | $-20.7M | ||
| Q4 24 | $-6.6M | $-48.8M | ||
| Q3 24 | $-16.2M | $-12.5M | ||
| Q2 24 | — | $-16.6M | ||
| Q1 24 | $15.6M | $-25.5M |
| Q4 25 | — | 40.2% | ||
| Q3 25 | 25.0% | 36.6% | ||
| Q2 25 | — | 48.9% | ||
| Q1 25 | 28.0% | 36.8% | ||
| Q4 24 | 34.0% | 32.4% | ||
| Q3 24 | 21.8% | 44.5% | ||
| Q2 24 | — | 43.0% | ||
| Q1 24 | 33.3% | 26.5% |
| Q4 25 | — | -164.1% | ||
| Q3 25 | -9.9% | -166.1% | ||
| Q2 25 | — | -122.7% | ||
| Q1 25 | -25.7% | -106.5% | ||
| Q4 24 | -6.0% | -144.1% | ||
| Q3 24 | -46.9% | -48.0% | ||
| Q2 24 | — | -48.6% | ||
| Q1 24 | -2.5% | -34.4% |
| Q4 25 | — | -176.6% | ||
| Q3 25 | -32.1% | -155.3% | ||
| Q2 25 | — | 623.4% | ||
| Q1 25 | -42.0% | -86.5% | ||
| Q4 24 | -20.2% | -225.2% | ||
| Q3 24 | -65.7% | -43.7% | ||
| Q2 24 | — | -65.2% | ||
| Q1 24 | 43.8% | -73.3% |
| Q4 25 | — | $-0.85 | ||
| Q3 25 | $-0.29 | $-0.61 | ||
| Q2 25 | — | $3.72 | ||
| Q1 25 | $-0.47 | $-0.77 | ||
| Q4 24 | $-0.25 | $-1.93 | ||
| Q3 24 | $-0.53 | $-0.50 | ||
| Q2 24 | — | $-0.68 | ||
| Q1 24 | $0.42 | $-1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $81.8M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $112.9M |
| Total Assets | $235.2M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $81.8M | ||
| Q3 25 | $18.9M | $96.8M | ||
| Q2 25 | — | $117.6M | ||
| Q1 25 | $5.4M | $35.9M | ||
| Q4 24 | $9.5M | $19.2M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $45.8M | ||
| Q1 24 | — | $63.7M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | $103.7M | ||
| Q4 24 | $111.3M | $103.1M | ||
| Q3 24 | $106.3M | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | $97.1M | $123.1M |
| Q4 25 | — | $112.9M | ||
| Q3 25 | $-10.5M | $133.1M | ||
| Q2 25 | — | $149.2M | ||
| Q1 25 | $2.2M | $3.7M | ||
| Q4 24 | $15.4M | $-11.7M | ||
| Q3 24 | $-3.9M | $30.8M | ||
| Q2 24 | — | $40.3M | ||
| Q1 24 | $17.7M | $52.5M |
| Q4 25 | — | $211.0M | ||
| Q3 25 | $235.2M | $224.3M | ||
| Q2 25 | — | $239.5M | ||
| Q1 25 | $237.7M | $208.8M | ||
| Q4 24 | $255.4M | $193.6M | ||
| Q3 24 | $246.8M | $224.2M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | $246.2M | $252.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | 27.92× | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 5.49× | 2.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-4.3M |
| Free Cash FlowOCF − Capex | $25.0K | $-16.2M |
| FCF MarginFCF / Revenue | 0.1% | -102.1% |
| Capex IntensityCapex / Revenue | 5.6% | 75.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-92.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.3M | ||
| Q3 25 | $1.8M | $-12.0M | ||
| Q2 25 | — | $-35.1M | ||
| Q1 25 | $1.2M | $-8.4M | ||
| Q4 24 | $-6.1M | $-19.2M | ||
| Q3 24 | $-613.0K | $14.0M | ||
| Q2 24 | — | $-4.4M | ||
| Q1 24 | $-1.4M | $-8.8M |
| Q4 25 | — | $-16.2M | ||
| Q3 25 | $25.0K | $-20.4M | ||
| Q2 25 | — | $-38.7M | ||
| Q1 25 | $-4.3M | $-17.3M | ||
| Q4 24 | $-8.6M | $-24.3M | ||
| Q3 24 | $-4.0M | $5.1M | ||
| Q2 24 | — | $-9.9M | ||
| Q1 24 | $-7.8M | $-15.9M |
| Q4 25 | — | -102.1% | ||
| Q3 25 | 0.1% | -161.3% | ||
| Q2 25 | — | -201.7% | ||
| Q1 25 | -12.1% | -72.6% | ||
| Q4 24 | -26.3% | -112.2% | ||
| Q3 24 | -16.3% | 17.8% | ||
| Q2 24 | — | -39.0% | ||
| Q1 24 | -21.8% | -45.7% |
| Q4 25 | — | 75.1% | ||
| Q3 25 | 5.6% | 66.2% | ||
| Q2 25 | — | 18.8% | ||
| Q1 25 | 15.5% | 37.3% | ||
| Q4 24 | 7.5% | 23.5% | ||
| Q3 24 | 13.9% | 31.2% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | 17.8% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
SPIR
Segment breakdown not available.
